Risk factors and intervention for chronic obstructive pulmonary disease in China

Respirology

Volumn 18, Issue , 2013, Pages 4-9

  Zhou, Yumin ^a   Chen, Rongchang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

China; Chronic obstructive pulmonary disease; Intervention; Risk factor

Indexed keywords

CIGARETTE SMOKE; COAL;

AGE DISTRIBUTION; ASTHMA; BIOMASS; BODY MASS; CHEMICAL STIMULATION; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBUSTION; COST EFFECTIVENESS ANALYSIS; DNA POLYMORPHISM; DUST; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; INCIDENCE; INDOOR AIR POLLUTION; LUNG TUBERCULOSIS; MULTIFACTORIAL INHERITANCE; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PASSIVE SMOKING; PHYSICAL STIMULATION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SOCIAL STATUS; INTERVENTION; POLLUTION;

CHINA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; INTERVENTION; RISK FACTOR;

CHINA; ENVIRONMENTAL POLLUTION; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84896318070     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12190     Document Type: Review

References (59)

1. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat.Med. 1998; 4: 1241-3.
2. Zhong N, Wang C, Yao W., etal. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am. J. Respir. Crit. Care Med. 2007; 176: 753-60.
3. Anderson D, Ferris BG., Jr. Role of tobacco smoking in the causation of chronic respiratory disease. N. Engl. J. Med. 1962; 267: 787-94.
4. Hou G, Yi Y, Sun L et al. A study on epidemiological morbidity and risk factors for chronic obstructive pulmonary disease in the populations higher than 35 in communities. Chin. Gen. Pract. 2012; 15: 1831-3.
5. Yao W, Zhu H, Shen N., et al. Epidemiology for chronic obstructive pulmonary disease in Yanqing county of Beijing. J. Peking Univ. (Health Sci.) 2005; 37: 121-5.
6. Burchfiel CM, Marcus EB, Sharp DS et al. Characteristics associated with rapid decline in forced expiratory volume. Ann. Epidemiol. 1996; 6: 217-27.
7. Zhou Y, Hu G, Wang D.,et al. Community-based integrated intervention and prevention for chronic obstructive pulmonary disease in Guangdong, China, a cluster randomised control trial. BMJ 2010; 341: c6387.
8. Burchfiel CM, Marcus EB, Curb JD et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am. J. Respir. Crit. Care Med. 1995; 151: 1778-85.
9. Higgins MW, Enright PL, Kronmal RA et al. Smoking and lung function in elderly men and women. The Cardiovascular Health Study. JAMA 1993; 269: 2741-8.
10. Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. N. Engl. J.Med. 2011; 364: 2469-70.
11. Fullerton DG, Bruce N, Gordon SB. Indoor air pollution from biomass fuel smoke is a major health concern in the developing world. Trans. R. Soc. Trop.Med. Hyg. 2008; 102: 843-51.
12. Liu S, Wang X, Wang D., et al. An investigation on the morbidity of chronic obstructive pulmonary disease in some areas in Guangdong. Chin.Med. J. 2005; 85: 747-52.
13. Liu S, Zhou Y, Wang X et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007; 62: 889-97.
14. Xu X, Yan Y, Yi H. Effects of biofuel smoke on pulmonary functions of healthy women in rural areas. Chin. J. Pract. Med. 2010; 37: 26-7.
15. Chapman RS, He X, Blair AE et al. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ 2005; 331: 1050.
16. Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull. World Health Organ. 2000; 78: 1078-92.
17. Smith KR. Indoor air pollution in developing countries: recommendations for research. Indoor Air 2002; 12: 198-207.
18. Liu Y, Lee K, Perez-Padilla R et al. Outdoor and indoor air pollution and COPD-related diseases in high-and low-income countries. Int. J. Tuberc. Lung Dis. 2008; 12: 115-27.
19. Mestl HE, Aunan K, Seip HM et al. Urban and rural exposure to indoor air pollution from domestic biomass and coal burning across China. Sci. Total Environ. 2007; 377: 12-26.
20. Yin P, Jiang CQ, Cheng KK et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007; 370: 751-7.
21. Zhou Y, Wang C, Yao W.,et al. COPD in Chinese nonsmokers. Eur. Respir. J. 2009; 33: 509-18.
22. Gu D, Wu X, Reynolds K., et al. Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am. J. Public Health 2004; 94: 1972-6.
23. Chester EH, Gillespie DG, Krause FD. The prevalence of chronic obstructive pulmonary disease in chlorine gas workers. Am. Rev. Respir. Dis. 1969; 99: 365-73.
24. Eduard W, Pearce N, Douwes J. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest 2009; 136: 716-25.
25. Becklake MR. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1989; 140: S85-91.
26. Husman K, Koskenvuo M, Kaprio J et al. Role of environment in the development of chronic bronchitis. Eur. J. Respir. Dis. Suppl. 1987; 152: 57-63.
27. Weinmann S, Vollmer WM, Breen V et al. COPD and occupational exposures: a case-control study. J. Occup. Environ. Med. 2008; 50: 561-9.
28. Min L, Yan R, Anshuan G., et al. An investigation on the risk factors for chronic obstructive pulmonary disease in rural areas in Xinjiang. Chin. J. Tuberc. Respir. Dis. 2011; 34: 666-8.
29. Zhou Y, Wang C, Yao W et al. Effects of vocational contact with dusts and smoke on symptoms of chronic obstructive pulmonary disease and respiratory tract. Chin. J. Respir. Crit. Care Med. 2009; 18: 6-11.
30. Technical Guidance Group of the Fifth National TB Epidemiological Survey/The Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin. J. Antituberc. 2012; 34: 485-508.
31. Lam KB, Jiang CQ, Jordan RE et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest 2010; 137: 593-600.
32. Leel C-H, Lee M-C, Lin H-H et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronicobstructive pulmonary disease. PLoS ONE 2012; 7: e37978.
33. Yin P, Zhang M, Li Y et al. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health 2011; 11: 586.
34. Ran P, Wang C, Yao W et al. The relationship between body weight index, chronic obstructive pulmonary disease and life quality. Chin. J. Tuberc. Respir. Dis. 2007; 30: 18-22.
35. Jiazina T, Hu X, Zhao S et al. An epidemiological study on chronic obstructive pulmonary disease in the Uygur residents higher than 60 in rural areas in Hetian of Xinjiang. J. Xinjiang Med. Univ. 2010; 3: 1017-20.
36. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr. Opin. Pulm. Med. 2004; 10: 98-103.
37. Kirkpatrick DP, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr. Opin. Pulm. Med. 2009; 15: 100-4.
38. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur. Respir. J. 1994; 7: 477-83.
39. Prescott E, Bjerg AM, Andersen PK et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur. Respir. J. 1994; 10: 822-7.
40. Camilli AE, Burrows B, Knudson RJ et al. Longitudinal changes in forced expiratory volume in one second in adults. Am. Rev. Respir. Dis. 1987; 135: 794-9.
41. Peat JK, Woolcock AJ, Cullen K. Decline of lung function and development of chronic airflow limitation: a longitudinal study of smokers and non-smokers in Busselton. Western Australia. Thorax 1990; 45: 32-7.
42. Anthonisen NR, Connett JE, Murray RP, for the Lung Health Study Research Group. Smoking and lung function of lung health study participants after 11 years. Am. J. Respir. Crit. Care Med. 2002; 166: 675-9.
43. Menezes AM, Perez-Padilla R, Jardim JR et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-81.
44. Silva GE, Sherrill DL, Guerra S et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.
45. Lange P, Parner J, Vestbo J et al. A 15-year followup study of ventilatory function in adults with asthma. N. Engl. J.Med. 1998; 339: 1194-200.
46. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J. Allergy Clin. Immunol. 2000; 105: 1041-53.
47. Bingbing L, Quanying H, Qing C et al. An investigation for estimating related factors for pulmonary functions in children of patients with chronic obstructive pulmonary disease. Chin.Med. J. 2002; 82: 1136-9.
48. Zhou M, Huang S, Wan H et al. The relationship between gene polymorphism of β-defensin-l and susceptibility of chronic obstructive pulmonary disease in Han people in south China. Med. Shanghai 2004; 27: 888-90.
49. He B, Jiang L, Ning L et al. A study on the correlation between the genotype at position-1055 in the promoter for interleukin-13 gene and chronic obstructive pulmonary disease. Chin. J. Tuberc. Respir. Dis. 2004; 27: 529-32.
50. Zhou M, Huang S, Wan H et al. The relationship between the gene polymorphism and COPD susceptibility in Han people in south China. J. Second Med. Univ. Shanghai 2004; 24: 81-4.
51. Liu S, Li B, Zhou Y et al. Genetic analysis of ccl6, 0GGl, GCLC polymorphisms and susceptibility to COPD. Respirology 2007; 12: 29-33.
52. Ma Z, Zhang Z, Han Z et al. A study on gene polymorphism of GSTM1 and GSTT1 and COPD susceptibility. Chin. J. Physicians 2004; 6: 721-4.
53. Xiao D, Wang C, Du M et al. The relationship between the gene polymorphism of microsomal epoxide hydrolase and chronic obstructive pulmonary disease. Chin.Med. J. 2003; 83: 1782-6.
54. Anthonisen NR, Connett JE. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV 1 the lung health study. JAMA 1994; 272: 1497-505.
55. Willemse BW, Postma DS, Timens W et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur. Respir. J. 2004; 23: 464-76.
56. Omori H, Nonami Y, Morimoto Y. Effect of smoking on FEV 1 decline in a cross-sectional and longitudinal study of a large cohort of Japanese males. Respirology 2005; 10: 464-9.
57. Zhou YM, Wang C, Yao WZ et al. Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China. Zhonghua Nei Ke Za Zhi 2009; 48: 358-61.
58. Gu D, Wu X, Reynolds K et al. Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am. J. Public Health 2004; 94: 1972-6.
59. Yang G, Fan L, Tan J et al. Smoking in China, finding of the 1996 national prevalence of survey. JAMA 1999; 282: 1247-53.